Press Release United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis 31 October 2023
Press Release Alzheon CEO Dr. Martin Tolar to Discuss Positive Results from Phase 2 Biomarker Study and Upcoming Readout from Pivotal APOLLOE4 Phase 3 Study Evaluating Oral ALZ-801/Valiltramiprosate at Truist Securities BioPharma Symposium 31 October 2023
Press Release Experian Health survey shows unanimous agreement that the staffing crisis is impacting revenue cycle management and patient engagement efforts 31 October 2023
Press Release KuCoin’s Survey Report Reveals Insights into UAE’s Role as a Crypto Hub, With 72% Preference in Bitcoin Investment 31 October 2023
Press Release Flashpoint Announces New Joint Venture Fund Targeting $150 Million to Invest in Direct Secondaries 31 October 2023
